NGNE
Neurogene Inc
NASDAQ: NGNE · HEALTHCARE · BIOTECHNOLOGY
$26.48
-3.53% today
Updated 2026-04-29
Market cap
$422.41M
P/E ratio
—
P/S ratio
438.73x
EPS (TTM)
$-4.24
Dividend yield
—
52W range
$12 – $37
Volume
0.2M
Neurogene Inc (NGNE) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
7 of 8
Last 8 quarters
Avg EPS surprise
+8.4%
Last 4 quarters
Revenue YoY growth
—
Most recent quarter
EPS YoY growth
-14.1%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
-6.5%
Last 2 reports
Positive reaction rate
50%
1 of 2 quarters
Largest single-day move
-26.7%
2025-11-13
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-03-24 | $-1.13 | +8.7% | $19.36 | $22.03 | +13.8% |
| 2025-11-13 | $-0.99 | +16.1% | $31.08 | $22.77 | -26.7% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $-1.24 | $-1.13 | +8.7% | — | — |
| 2025-09-30 | $-1.18 | $-0.99 | +16.1% | — | — |
| 2025-06-30 | $-1.11 | $-1.05 | +5.4% | — | — |
| 2025-03-31 | $-1.12 | $-1.08 | +3.6% | — | — |
| 2024-12-31 | $-1.13 | $-0.99 | +12.3% | $-925000.00 | — |
| 2024-09-30 | $-1.22 | $-1.19 | +2.3% | — | — |
| 2024-06-30 | $-1.05 | $-1.09 | -3.8% | $925000.00 | — |
| 2024-03-31 | $-1.13 | $-1.00 | +11.5% | — | — |
| 2023-12-31 | $-1.17 | $-1.51 | -29.1% | — | — |
| 2023-09-30 | $-0.03 | $-0.41 | -1259.0% | — | — |
| 2023-06-30 | $-0.04 | $-0.04 | +0.0% | — | — |
| 2023-03-31 | $-0.22 | $-0.26 | -18.2% | — | — |
Frequently asked questions
Has Neurogene Inc beaten earnings estimates?
Neurogene Inc has beaten Wall Street EPS estimates in 7 of its last 8 quarterly reports, with an average EPS surprise of +8.4% over the last 4 quarters.
How does NGNE stock react to earnings?
NGNE stock has moved an average of -6.5% in the trading day following earnings over its last 2 reports, with positive reactions in 50% of those quarters.